Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp44805_8k.htm |
Exhibit 99.1
|
Press Release
|
 |
|
www.shire.com
|
Director Declaration
March 14, 2014 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces that its Non-Executive Director, William Burns, was appointed as a Non-Executive Director of Mesoblast Limited on March 6, 2014.
This disclosure is made pursuant to paragraph 9.6.14 of the UK Listing Rules.
Tony Guthrie
Deputy Company Secretary
For further information please contact:
|
Investor Relations
|
||
|
Laurie Stelzer
|
lstelzer@shire.com
|
+1 781 482 0733
|
|
Eric Rojas
|
erojas@shire.com
|
+1 781 482 0999
|
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX